| Announce Date | 02/10/2026 |
| EPS Normalized Actual | $0.3472 (Miss by $-0.1828) |
| EPS GAAP Actual | $0.3472 (Miss by $-0.1828) |
| Revenue Actual | $1.73601B |
| Revenue Surprise | Beat by $1736.01M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.13569 |
| EPS GAAP Estimate | $-0.13569 |
| Revenue Estimate | $0.893438585B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2030 | 1.75 | 9.42 | 1.71499 | 1.79329 | 1 |
| Dec 2029 | 2.21 | 7.46 | 2.17075 | 2.26574 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.85 | 0.65043 | 1.73601B | -6.21% | 618.93M |
| FQ2 2025 (Jun 2025) | 0.16 | 0.16 | 1.01857B | -6% | 1018.57M |
| FQ1 2025 (Mar 2025) | -0.12 | -0.12 | 0.8266B | 2.07% | 826.6M |
| FQ4 2024 (Dec 2024) | 0.41 | 0.41 | 1.6464B | 1.56% | 1646.4M |
| FQ3 2024 (Sep 2024) | 1.09 | 1.09 | 1.84386B | -4.06% | 1843.86M |
| FQ2 2024 (Jun 2024) | 0.17 | 0.17 | 1.0797B | -0.69% | 1079.7M |
| FQ1 2024 (Mar 2024) | -0.0816 | -0.0816 | 0.8095B | -0.63% | 809.5M |
| FQ4 2023 (Dec 2023) | 0.42 | 0.42 | 1.6207B | 13.5% | 1620.7M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.13569
Consensus Revenue Estimates
0.893438585B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.42807 | -- | 0.40267 | 0.45332 | 2 |
| FQ3 2027 (Sep 2027) | 1.31984 | -- | 1.24154 | 1.39769 | 2 |
| FQ2 2027 (Jun 2027) | 0.24073 | -- | 0.22645 | 0.25493 | 2 |
| FQ1 2027 (Mar 2027) | -0.10801 | -- | -0.11438 | -0.1016 | 2 |
| FQ4 2026 (Oct 2026) | 1.13197 | -- | 1.06096 | 1.19305 | 3 |
| FQ3 2026 (Jul 2026) | 0.24127 | -252.3 | 0.22614 | 0.25429 | 5 |
| FQ2 2026 (Jun 2026) | 0.24127 | 33.68 | 0.2245 | 0.25442 | 5 |
| FQ1 2026 (Mar 2026) | -0.13569 | 11.56 | -0.14308 | -0.12626 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.71B | -- | 1.63B | 1.79B | 3 |
| FQ3 2027 (Sep 2027) | 1.91B | -- | 1.83B | 2B | 3 |
| FQ2 2027 (Jun 2027) | 1.16B | -- | 1.11B | 1.21B | 3 |
| FQ1 2027 (Mar 2027) | 0.78B | -- | 0.74B | 0.81B | 3 |
| FQ4 2026 (Oct 2026) | 1.94B | -- | 1.84B | 2.02B | 4 |
| FQ3 2026 (Jul 2026) | 1.2B | -45.07 | 1.14B | 1.25B | 5 |
| FQ2 2026 (Jun 2026) | 1.2B | 14.88 | 1.13B | 1.25B | 6 |
| FQ1 2026 (Mar 2026) | 0.89B | 7.48 | 0.85B | 0.93B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.19957 | 0.85 | 0.65043 | 76.52% |
| FQ2 2025 (Jun 2025) | 0.16 | 0.16 | 100% | |
| FQ1 2025 (Mar 2025) | -0.12 | -0.12 | 100% | |
| FQ4 2024 (Dec 2024) | 0.41 | 0.41 | 100% | |
| FQ3 2024 (Sep 2024) | 1.09 | 1.09 | 100% | |
| FQ2 2024 (Jun 2024) | 0.17 | 0.17 | 100% | |
| FQ1 2024 (Mar 2024) | -0.0816 | -0.0816 | 100% | |
| FQ4 2023 (Dec 2023) | 0.42 | 0.42 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.12B | $1.74B | $618.93M | 35.65% |
| FQ2 2025 (Jun 2025) | $0B | $1.02B | $1018.57M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.83B | $826.6M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.65B | $1646.4M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.84B | $1843.86M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.08B | $1079.7M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.81B | $809.5M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.62B | $1620.7M | 100% |